Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer.
Saved in:
| Title: | Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. |
|---|---|
| Authors: | Herzog SK; Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, Texas.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Stevens JH; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Gu G; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Grimm SL; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Cardoza K; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Hawkins AGM; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, Texas., Lin H; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Ramos D; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Beyer AR; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Edwards DG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Dustin D; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas., Yang HJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Liang N; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Khan AF; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas., Bawa-Khalfe T; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas., McGrail DJ; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio., Lin SY; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Fuqua SAW; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. |
| Source: | Cancer research [Cancer Res] 2026 Apr 02; Vol. 86 (7), pp. 1707-1723. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
